InvestorsHub Logo
Followers 3
Posts 178
Boards Moderated 0
Alias Born 04/03/2016

Re: None

Wednesday, 08/01/2018 3:42:27 PM

Wednesday, August 01, 2018 3:42:27 PM

Post# of 113
letter from GA today

Hello;

Have had a lot of people asking about sales and when they will be announced and so we have put out the attached news release to address this important subject.

Background on today’s news release:

1. I am encouraged by the contacts with leading cardiologists that see many special situations where the information the VMS+ provides would greatly enhance the ability to properly diagnose, treat and monitor patients. This is great because making cardiac care better is our mission.
2. In June MD Anderson sent us the first purchase order and we have been working with them to set an installation date, which has now been set for the week of August 13th. This a big deal as this is the number one cancer center in the world. They will need 1,000 machines to address their 1.7 million patients each year, so this is just the first one of many more.
3. We have 5 other leading centres in US, Europe and Canada who have made the decision to buy the VMS+ and are going through their process to issue a purchase order. It is a slow business as hospitals have complex procedures to be sure they only buy what they need. While it is nice to know they absolutely need the VMS+, it is still frustrating. We have the machines ready to be installed so just waiting on the PO.
4. These new centres will also need many VMS+ machines to address their patient population so these are the first of many.
4. We are working hard to adapt the VMS+ so we can offer a subscription model for hospitals so they can get started quickly and we can move away from the capital purchase model. This is the trend in medical imaging - to outsource analysis - to allow cardiologists to focus on patient care and treatment. This will be the topic of the next update news release next week.

Thanks for the support in the public market.

Please call me if you haven questions.

Regards,

George Adams, PhD, ICD.D
CEO
Ventripoint Diagnostics Ltd..
Cell: 519-803-6937
TSXV: VPT